Global Filgrastim Biosimilars Market Research Report 2023: Focus on Zarxio, Nivestym, and Releuko
May 02, 2023 06:03 ET
|
Research and Markets
Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global filgrastim biosimilars market...
Cancer Pain Management Market Report 2023: Featuring Daiichi Sankyo, Hisamitsu Pharmaceutical, Pfizer, Sanofi & More
April 27, 2023 06:08 ET
|
Research and Markets
Dublin, April 27, 2023 (GLOBE NEWSWIRE) -- The "Cancer Pain Management Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Chemotherapy Drugs Market Insights, Competitive Landscape, and Market Forecasts, 2027
April 13, 2023 10:18 ET
|
Research and Markets
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Chemotherapy Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2027" drug pipelines has been added to ResearchAndMarkets.com's...
LIXTE Biotechnology Announces Sarah Cannon Research Institute Joins City of Hope’s Ongoing Phase 1b Clinical Trial in Evaluating Lixte’s Lead Anti-Cancer Compound, LB-100, in Small Cell Lung Cancer
April 04, 2023 08:30 ET
|
Lixte Biotechnology Holdings, Inc.
Clinical Trial Focuses on Assessing Whether LB-100 Enhances the Effectiveness of a Standard Regimen Combining Immunotherapy and Chemotherapy for Untreated Small Cell Lung Cancer as it Does in Animal...
Rising Cases of Cancer among Infants to Steer Pediatric Neuroblastoma Treatment Market Past US$ 5.3 Billion by 2033 | Fact.MR Report
March 30, 2023 13:00 ET
|
FACT.MR
Rockville , March 30, 2023 (GLOBE NEWSWIRE) -- Fact.MR – A Market Research and Competitive Intelligence Provider: The global pediatric neuroblastoma treatment market is currently valued at US$ 2.1...
Immune Checkpoint Inhibitors Lead the Bladder Cancer Treatment Drugs Market with US$ 14.8 Billion in Revenue by 2033: Persistence Market Research
March 28, 2023 09:35 ET
|
Persistence Market Research
New York, March 28, 2023 (GLOBE NEWSWIRE) -- As per this new industry analysis by Persistence Market Research, the global Bladder Cancer Treatment Drugs Market was valued at US$ 3.04 billion in 2022...
Retinoblastoma Treatment Global Market Report 2023: Sector to Reach $3.5 Billion by 2028 at a 4.4% CAGR
March 22, 2023 08:43 ET
|
Research and Markets
Dublin, March 22, 2023 (GLOBE NEWSWIRE) -- The "Retinoblastoma Treatment Market by Type, Treatment Type, Type of Staging, Application, and Region 2023-2028" report has been added to ...
Enlivex Receives Positive DSMB Recommendation and IMOH Clearance to Continue Phase I/II Trial of Allocetra combined with chemotherapy in patients with peritoneal metastases arising from solid cancers
March 20, 2023 08:00 ET
|
Enlivex Therapeutics Ltd
Nes-Ziona, Israel, March 20, 2023 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that...
AL Amyloidosis Therapeutics Market is projected to rise at a 7.3% CAGR until 2033, being valued at US$ 4.56 billion | Future Market Insights, Inc.
March 20, 2023 06:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 20, 2023 (GLOBE NEWSWIRE) -- The global AL amyloidosis therapeutics market is expected to be worth US$ 2.25 billion by the year of 2023. The market, which is estimated to be worth...
Volumetric Infusion Pumps Market to Cross US$ 1.7 Billion Revenues in 2033 at a CAGR of 5.9% | Persistence Market Research
March 07, 2023 07:30 ET
|
Persistence Market Research
New York, March 07, 2023 (GLOBE NEWSWIRE) -- The global Volumetric Infusion Pumps Market is valued at around 927.3 Million in 2022 and Sales of the Volumetric Infusion Pumps Market are set to...